MiR‐125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK‐STAT3 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR‐125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK‐STAT3 pathway

Published:2018-09-11 Issue:2 Volume:120 Page:2616-2626
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Xiao Tao¹,Zhou You¹,Li Hui¹,Xiong Liang¹,Wang Jing¹²,Wang Zhi‐Hua¹³,Liu Li‐Hong¹^ORCID

Affiliation:

1. Department of Orthopedics The Second Xiangya Hospital, Central South University Changsha China

2. Department of Orthopedics Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University Changsha China

3. Department of Orthopedics Chenzhou No. 1 People’s Hospital Chenzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27568

Reference46 articles.

1. Advances in the management of osteosarcoma

2. Osteosarcoma Overview

3. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

4. Osteosarcoma incidence and survival rates from 1973 to 2004

5. Dysregulation of microRNA biogenesis and gene silencing in cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA PCED1B-AS1 mediates miR-3681-3p/MAP2K7 axis to promote metastasis, invasion and EMT in gastric cancer;Biology Direct;2024-05-02

2. MiR-125b targeted regulation of MKNK2 inhibits multiple myeloma proliferation and invasion;American Journal of Translational Research;2024

3. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies;MedComm;2023-07-10

4. MALAT1 regulates PCT expression in sepsis patients through the miR‐125b/STAT3 axis;Journal of Clinical Laboratory Analysis;2022-04-15

5. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis;Experimental Hematology & Oncology;2022-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3